Le Lézard
Classified in: Health, Science and technology
Subject: Conference

Xeris to Present at the Oppenheimer 34th Annual Healthcare Life Science Conference


Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies, today announced that Paul R. Edick, Xeris' Chairman and CEO, will present an overview of the Company at the Oppenheimer 34th Annual Healthcare Life Sciences Conference on Tuesday, February 13, 2024 at 10:00 am Eastern Time. To access the presentation, please visit "Events" on the investor relations page of the Company's website at www.xerispharma.com.

About Xeris

Xeris (Nasdaq: XERS) is a growth-oriented biopharmaceutical company committed to improving patients' lives by developing and commercializing innovative products across a range of therapies. Xeris has three commercially available products; Gvoke®, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia, Keveyis®, a proven therapy for primary periodic paralysis, and Recorlev® for the treatment of endogenous Cushing's syndrome. Xeris also has a robust pipeline of development programs to extend the current marketed products into important new indications and uses and bring new products forward using its proprietary formulation technology platforms, XeriSoltm and XeriJect®, supporting long-term product development and commercial success.

Xeris Biopharma Holdings is headquartered in Chicago, IL. For more information, visit www.xerispharma.com, or follow us on X, LinkedIn, or Instagram.


These press releases may also interest you

at 22:05
LC-Plasma-based Vaccine Research Selected for SCARDA Project
Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis strain Plasma [postbiotic] (LC-Plasma) immunization...

at 22:00
NSG BioLabs Fuels Biotech Innovation in Singapore and Southeast Asia Through Partnerships with EnterpriseSG and Merck, Alongside Investments from Celadon Partners and ClavystBio
Since 2019, NSG BioLabs has been a leader in co-working lab spaces in Singapore, and has nurtured over 40 biotech companies, of which the startups have achieved nearly US$400 million funding in total alongside significant business milestonesNSG...

at 21:05
Lifenet Insurance to Improve Employee Work Efficiency
Ivanti Software K.K., the Japanese subsidiary of Ivanti, a tech company that breaks barriers between IT and security departments so that Everywhere Work can thrive, and Lifenet Insurance Co. (Lifenet Insurance), today announced that Ivanti Neurons...

at 21:00
AGON by AOC secures number 1 spot as the world's leading gaming monitor brand
TPV USA, leading display specialist and North America brand license partner for AOC gaming monitors, proudly announces its position as the world's number one gaming monitor brand, per the IDC Quarterly Gaming Tracker report for Q1/2024. AGON by AOC...

at 20:35
INSERTING and REPLACING ZYUS Life Sciences Corporation to Present at Sidoti Virtual Investor Conference May 8-9
Insert as subheadline: NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES The updated release reads: ZYUS LIFE SCIENCES CORPORATION TO PRESENT AT SIDOTI VIRTUAL INVESTOR CONFERENCE MAY 8-9 NOT FOR...

at 20:30
DataShapes AI Taps Kevin Larrabee As Head of Product
DataShapes, Inc., the premier developer of cutting-edge AI solutions targeting the electromagnetic spectrum, announced today that it has named Kevin Larrabee as Head of Product for the company's pioneering AI technology for defense and enterprise...

More news about Science and technology...


News published on and distributed by: